nodes	percent_of_prediction	percent_of_DWPC	metapath
Promazine—DRD4—attention deficit hyperactivity disorder	0.212	0.271	CbGaD
Promazine—DRD1—attention deficit hyperactivity disorder	0.18	0.229	CbGaD
Promazine—ADRA2A—attention deficit hyperactivity disorder	0.167	0.213	CbGaD
Promazine—DRD2—attention deficit hyperactivity disorder	0.127	0.162	CbGaD
Promazine—HTR2A—attention deficit hyperactivity disorder	0.0979	0.125	CbGaD
Promazine—HTR2A—locus ceruleus—attention deficit hyperactivity disorder	0.00391	0.0875	CbGeAlD
Promazine—HTR2A—autonomic nervous system—attention deficit hyperactivity disorder	0.00208	0.0465	CbGeAlD
Promazine—ADRA1D—forebrain—attention deficit hyperactivity disorder	0.00131	0.0292	CbGeAlD
Promazine—DRD1—forebrain—attention deficit hyperactivity disorder	0.00124	0.0278	CbGeAlD
Promazine—DRD4—brain—attention deficit hyperactivity disorder	0.00103	0.0229	CbGeAlD
Promazine—CHRM4—nervous system—attention deficit hyperactivity disorder	0.00101	0.0227	CbGeAlD
Promazine—CHRM2—forebrain—attention deficit hyperactivity disorder	0.001	0.0224	CbGeAlD
Promazine—CHRM4—central nervous system—attention deficit hyperactivity disorder	0.000976	0.0218	CbGeAlD
Promazine—HTR2C—forebrain—attention deficit hyperactivity disorder	0.000966	0.0216	CbGeAlD
Promazine—CHRM1—forebrain—attention deficit hyperactivity disorder	0.000912	0.0204	CbGeAlD
Promazine—CHRM2—cardiovascular system—attention deficit hyperactivity disorder	0.000848	0.0189	CbGeAlD
Promazine—DRD1—midbrain—attention deficit hyperactivity disorder	0.000821	0.0184	CbGeAlD
Promazine—CHRM3—forebrain—attention deficit hyperactivity disorder	0.000816	0.0183	CbGeAlD
Promazine—CHRM5—nervous system—attention deficit hyperactivity disorder	0.000793	0.0177	CbGeAlD
Promazine—CHRM4—brain—attention deficit hyperactivity disorder	0.000775	0.0173	CbGeAlD
Promazine—CHRM1—cardiovascular system—attention deficit hyperactivity disorder	0.000771	0.0172	CbGeAlD
Promazine—CHRM5—central nervous system—attention deficit hyperactivity disorder	0.000763	0.0171	CbGeAlD
Promazine—ADRA1A—forebrain—attention deficit hyperactivity disorder	0.00075	0.0168	CbGeAlD
Promazine—DRD2—forebrain—attention deficit hyperactivity disorder	0.000735	0.0164	CbGeAlD
Promazine—ADRA1B—nervous system—attention deficit hyperactivity disorder	0.000724	0.0162	CbGeAlD
Promazine—ADRA1D—nervous system—attention deficit hyperactivity disorder	0.000709	0.0158	CbGeAlD
Promazine—ADRA1B—central nervous system—attention deficit hyperactivity disorder	0.000697	0.0156	CbGeAlD
Promazine—ADRA1D—central nervous system—attention deficit hyperactivity disorder	0.000682	0.0153	CbGeAlD
Promazine—DRD1—nervous system—attention deficit hyperactivity disorder	0.000675	0.0151	CbGeAlD
Promazine—DRD1—central nervous system—attention deficit hyperactivity disorder	0.00065	0.0145	CbGeAlD
Promazine—HTR2C—midbrain—attention deficit hyperactivity disorder	0.000638	0.0143	CbGeAlD
Promazine—ADRA1A—cardiovascular system—attention deficit hyperactivity disorder	0.000634	0.0142	CbGeAlD
Promazine—CHRM5—brain—attention deficit hyperactivity disorder	0.000606	0.0135	CbGeAlD
Promazine—HRH1—forebrain—attention deficit hyperactivity disorder	0.00058	0.013	CbGeAlD
Promazine—ADRA2A—forebrain—attention deficit hyperactivity disorder	0.00057	0.0127	CbGeAlD
Promazine—ADRA1B—brain—attention deficit hyperactivity disorder	0.000554	0.0124	CbGeAlD
Promazine—CHRM2—nervous system—attention deficit hyperactivity disorder	0.000544	0.0122	CbGeAlD
Promazine—ADRA1D—brain—attention deficit hyperactivity disorder	0.000542	0.0121	CbGeAlD
Promazine—HTR2C—nervous system—attention deficit hyperactivity disorder	0.000524	0.0117	CbGeAlD
Promazine—CHRM2—central nervous system—attention deficit hyperactivity disorder	0.000524	0.0117	CbGeAlD
Promazine—DRD1—brain—attention deficit hyperactivity disorder	0.000516	0.0115	CbGeAlD
Promazine—HTR2C—central nervous system—attention deficit hyperactivity disorder	0.000505	0.0113	CbGeAlD
Promazine—CYP2C9—cardiovascular system—attention deficit hyperactivity disorder	0.000498	0.0111	CbGeAlD
Promazine—CHRM1—nervous system—attention deficit hyperactivity disorder	0.000495	0.0111	CbGeAlD
Promazine—DRD2—midbrain—attention deficit hyperactivity disorder	0.000485	0.0108	CbGeAlD
Promazine—HTR2A—forebrain—attention deficit hyperactivity disorder	0.000485	0.0108	CbGeAlD
Promazine—CHRM1—central nervous system—attention deficit hyperactivity disorder	0.000477	0.0107	CbGeAlD
Promazine—CHRM3—nervous system—attention deficit hyperactivity disorder	0.000443	0.00991	CbGeAlD
Promazine—CHRM3—central nervous system—attention deficit hyperactivity disorder	0.000427	0.00954	CbGeAlD
Promazine—CHRM2—brain—attention deficit hyperactivity disorder	0.000416	0.0093	CbGeAlD
Promazine—HTR2A—cardiovascular system—attention deficit hyperactivity disorder	0.00041	0.00916	CbGeAlD
Promazine—ADRA1A—nervous system—attention deficit hyperactivity disorder	0.000407	0.0091	CbGeAlD
Promazine—HTR2C—brain—attention deficit hyperactivity disorder	0.000401	0.00896	CbGeAlD
Promazine—DRD2—nervous system—attention deficit hyperactivity disorder	0.000399	0.00892	CbGeAlD
Promazine—ADRA1A—central nervous system—attention deficit hyperactivity disorder	0.000392	0.00876	CbGeAlD
Promazine—DRD2—central nervous system—attention deficit hyperactivity disorder	0.000384	0.00859	CbGeAlD
Promazine—ADRA1A—cerebellum—attention deficit hyperactivity disorder	0.000383	0.00856	CbGeAlD
Promazine—CHRM1—brain—attention deficit hyperactivity disorder	0.000379	0.00846	CbGeAlD
Promazine—ADRA2A—midbrain—attention deficit hyperactivity disorder	0.000376	0.00841	CbGeAlD
Promazine—DRD2—cerebellum—attention deficit hyperactivity disorder	0.000375	0.00839	CbGeAlD
Promazine—CHRM3—brain—attention deficit hyperactivity disorder	0.000339	0.00757	CbGeAlD
Promazine—HTR2A—midbrain—attention deficit hyperactivity disorder	0.00032	0.00715	CbGeAlD
Promazine—HRH1—nervous system—attention deficit hyperactivity disorder	0.000315	0.00704	CbGeAlD
Promazine—ADRA1A—brain—attention deficit hyperactivity disorder	0.000311	0.00695	CbGeAlD
Promazine—ADRA2A—nervous system—attention deficit hyperactivity disorder	0.000309	0.00692	CbGeAlD
Promazine—DRD2—brain—attention deficit hyperactivity disorder	0.000305	0.00682	CbGeAlD
Promazine—HRH1—central nervous system—attention deficit hyperactivity disorder	0.000303	0.00678	CbGeAlD
Promazine—ADRA2A—central nervous system—attention deficit hyperactivity disorder	0.000298	0.00666	CbGeAlD
Promazine—ADRA2A—cerebellum—attention deficit hyperactivity disorder	0.000291	0.00651	CbGeAlD
Promazine—HTR2A—nervous system—attention deficit hyperactivity disorder	0.000263	0.00588	CbGeAlD
Promazine—HTR2A—central nervous system—attention deficit hyperactivity disorder	0.000253	0.00566	CbGeAlD
Promazine—HTR2A—cerebellum—attention deficit hyperactivity disorder	0.000248	0.00554	CbGeAlD
Promazine—CYP3A4—nervous system—attention deficit hyperactivity disorder	0.000244	0.00545	CbGeAlD
Promazine—HRH1—brain—attention deficit hyperactivity disorder	0.000241	0.00538	CbGeAlD
Promazine—Captodiame—DRD3—attention deficit hyperactivity disorder	0.000241	0.0312	CrCbGaD
Promazine—ADRA2A—brain—attention deficit hyperactivity disorder	0.000237	0.00529	CbGeAlD
Promazine—CYP3A4—central nervous system—attention deficit hyperactivity disorder	0.000234	0.00524	CbGeAlD
Promazine—Diltiazem—CACNA1C—attention deficit hyperactivity disorder	0.000204	0.0264	CrCbGaD
Promazine—HTR2A—brain—attention deficit hyperactivity disorder	0.000201	0.0045	CbGeAlD
Promazine—Acetophenazine—DRD1—attention deficit hyperactivity disorder	0.000185	0.024	CrCbGaD
Promazine—Methotrimeprazine—DRD5—attention deficit hyperactivity disorder	0.000166	0.0215	CrCbGaD
Promazine—Propericiazine—DRD1—attention deficit hyperactivity disorder	0.000164	0.0212	CrCbGaD
Promazine—Methotrimeprazine—ADRA2C—attention deficit hyperactivity disorder	0.000157	0.0203	CrCbGaD
Promazine—Quetiapine—DRD5—attention deficit hyperactivity disorder	0.000157	0.0203	CrCbGaD
Promazine—Doxepin—ADRA2C—attention deficit hyperactivity disorder	0.000153	0.0198	CrCbGaD
Promazine—Propericiazine—ADRA2A—attention deficit hyperactivity disorder	0.000152	0.0197	CrCbGaD
Promazine—Quetiapine—ADRA2C—attention deficit hyperactivity disorder	0.000148	0.0191	CrCbGaD
Promazine—Acetophenazine—DRD2—attention deficit hyperactivity disorder	0.000131	0.0169	CrCbGaD
Promazine—Chlorpromazine—DRD5—attention deficit hyperactivity disorder	0.000127	0.0164	CrCbGaD
Promazine—Triflupromazine—DRD1—attention deficit hyperactivity disorder	0.000114	0.0147	CrCbGaD
Promazine—Acepromazine—DRD1—attention deficit hyperactivity disorder	0.000105	0.0136	CrCbGaD
Promazine—Thioproperazine—DRD1—attention deficit hyperactivity disorder	0.000103	0.0133	CrCbGaD
Promazine—Mesoridazine—DRD3—attention deficit hyperactivity disorder	0.000102	0.0132	CrCbGaD
Promazine—Pipotiazine—DRD1—attention deficit hyperactivity disorder	0.000101	0.0131	CrCbGaD
Promazine—Chlorphenamine—SLC6A3—attention deficit hyperactivity disorder	0.000101	0.0131	CrCbGaD
Promazine—Propiomazine—DRD4—attention deficit hyperactivity disorder	9.93e-05	0.0129	CrCbGaD
Promazine—Prochlorperazine—DRD3—attention deficit hyperactivity disorder	9.85e-05	0.0127	CrCbGaD
Promazine—Cyamemazine—HTR2A—attention deficit hyperactivity disorder	8.92e-05	0.0115	CrCbGaD
Promazine—Fluphenazine—DRD3—attention deficit hyperactivity disorder	8.91e-05	0.0115	CrCbGaD
Promazine—Fluphenazine—DRD1—attention deficit hyperactivity disorder	8.74e-05	0.0113	CrCbGaD
Promazine—Benzphetamine—SLC6A3—attention deficit hyperactivity disorder	8.55e-05	0.0111	CrCbGaD
Promazine—Methotrimeprazine—DRD4—attention deficit hyperactivity disorder	8.49e-05	0.011	CrCbGaD
Promazine—Propiomazine—DRD1—attention deficit hyperactivity disorder	8.41e-05	0.0109	CrCbGaD
Promazine—Benzphetamine—ADRA2A—attention deficit hyperactivity disorder	8.38e-05	0.0108	CrCbGaD
Promazine—Cyclobenzaprine—HTR2A—attention deficit hyperactivity disorder	8.29e-05	0.0107	CrCbGaD
Promazine—Fluphenazine—ADRA2A—attention deficit hyperactivity disorder	8.12e-05	0.0105	CrCbGaD
Promazine—Chlorprothixene—DRD3—attention deficit hyperactivity disorder	8.11e-05	0.0105	CrCbGaD
Promazine—Triflupromazine—DRD2—attention deficit hyperactivity disorder	8.01e-05	0.0104	CrCbGaD
Promazine—Quetiapine—DRD4—attention deficit hyperactivity disorder	8.01e-05	0.0104	CrCbGaD
Promazine—Chlorprothixene—DRD1—attention deficit hyperactivity disorder	7.96e-05	0.0103	CrCbGaD
Promazine—Chlorphenamine—SLC6A4—attention deficit hyperactivity disorder	7.55e-05	0.00977	CrCbGaD
Promazine—Thioridazine—DRD1—attention deficit hyperactivity disorder	7.53e-05	0.00975	CrCbGaD
Promazine—Clomipramine—ADRA2A—attention deficit hyperactivity disorder	7.43e-05	0.00962	CrCbGaD
Promazine—Acepromazine—DRD2—attention deficit hyperactivity disorder	7.42e-05	0.0096	CrCbGaD
Promazine—Methotrimeprazine—DRD3—attention deficit hyperactivity disorder	7.32e-05	0.00948	CrCbGaD
Promazine—Thioproperazine—DRD2—attention deficit hyperactivity disorder	7.25e-05	0.00938	CrCbGaD
Promazine—Methotrimeprazine—DRD1—attention deficit hyperactivity disorder	7.19e-05	0.00931	CrCbGaD
Promazine—Pipotiazine—DRD2—attention deficit hyperactivity disorder	7.13e-05	0.00923	CrCbGaD
Promazine—Quetiapine—HTR1B—attention deficit hyperactivity disorder	7.11e-05	0.00921	CrCbGaD
Promazine—Mesoridazine—DRD2—attention deficit hyperactivity disorder	7.04e-05	0.00911	CrCbGaD
Promazine—Thioridazine—ADRA2A—attention deficit hyperactivity disorder	7e-05	0.00906	CrCbGaD
Promazine—Trimipramine—SLC6A3—attention deficit hyperactivity disorder	6.97e-05	0.00903	CrCbGaD
Promazine—Perphenazine—DRD1—attention deficit hyperactivity disorder	6.91e-05	0.00895	CrCbGaD
Promazine—Quetiapine—DRD3—attention deficit hyperactivity disorder	6.9e-05	0.00894	CrCbGaD
Promazine—Trimipramine—ADRA2A—attention deficit hyperactivity disorder	6.84e-05	0.00885	CrCbGaD
Promazine—Prochlorperazine—DRD2—attention deficit hyperactivity disorder	6.81e-05	0.00882	CrCbGaD
Promazine—Quetiapine—DRD1—attention deficit hyperactivity disorder	6.78e-05	0.00878	CrCbGaD
Promazine—Methotrimeprazine—ADRA2A—attention deficit hyperactivity disorder	6.68e-05	0.00865	CrCbGaD
Promazine—Doxepin—ADRA2A—attention deficit hyperactivity disorder	6.51e-05	0.00843	CrCbGaD
Promazine—Chlorpromazine—DRD4—attention deficit hyperactivity disorder	6.48e-05	0.00839	CrCbGaD
Promazine—Perphenazine—ADRA2A—attention deficit hyperactivity disorder	6.42e-05	0.00832	CrCbGaD
Promazine—Quetiapine—ADRA2A—attention deficit hyperactivity disorder	6.3e-05	0.00815	CrCbGaD
Promazine—Fluphenazine—DRD2—attention deficit hyperactivity disorder	6.16e-05	0.00798	CrCbGaD
Promazine—Desipramine—SLC6A3—attention deficit hyperactivity disorder	6.1e-05	0.00789	CrCbGaD
Promazine—Propiomazine—DRD2—attention deficit hyperactivity disorder	5.93e-05	0.00768	CrCbGaD
Promazine—Acepromazine—HTR2A—attention deficit hyperactivity disorder	5.73e-05	0.00742	CrCbGaD
Promazine—Amitriptyline—HTR1B—attention deficit hyperactivity disorder	5.69e-05	0.00737	CrCbGaD
Promazine—Clomipramine—SLC6A4—attention deficit hyperactivity disorder	5.67e-05	0.00734	CrCbGaD
Promazine—Chlorprothixene—DRD2—attention deficit hyperactivity disorder	5.61e-05	0.00727	CrCbGaD
Promazine—Thioproperazine—HTR2A—attention deficit hyperactivity disorder	5.6e-05	0.00725	CrCbGaD
Promazine—Chlorpromazine—DRD3—attention deficit hyperactivity disorder	5.59e-05	0.00723	CrCbGaD
Promazine—Amitriptyline—DRD3—attention deficit hyperactivity disorder	5.52e-05	0.00715	CrCbGaD
Promazine—Pipotiazine—HTR2A—attention deficit hyperactivity disorder	5.51e-05	0.00713	CrCbGaD
Promazine—Chlorpromazine—DRD1—attention deficit hyperactivity disorder	5.48e-05	0.0071	CrCbGaD
Promazine—Mesoridazine—HTR2A—attention deficit hyperactivity disorder	5.44e-05	0.00704	CrCbGaD
Promazine—Thioridazine—DRD2—attention deficit hyperactivity disorder	5.31e-05	0.00687	CrCbGaD
Promazine—Trimipramine—SLC6A4—attention deficit hyperactivity disorder	5.21e-05	0.00675	CrCbGaD
Promazine—Trimipramine—DRD2—attention deficit hyperactivity disorder	5.19e-05	0.00671	CrCbGaD
Promazine—Imipramine—SLC6A3—attention deficit hyperactivity disorder	5.17e-05	0.0067	CrCbGaD
Promazine—Chlorpromazine—ADRA2A—attention deficit hyperactivity disorder	5.1e-05	0.0066	CrCbGaD
Promazine—Methotrimeprazine—DRD2—attention deficit hyperactivity disorder	5.07e-05	0.00656	CrCbGaD
Promazine—Amitriptyline—ADRA2A—attention deficit hyperactivity disorder	5.04e-05	0.00652	CrCbGaD
Promazine—Promethazine—DRD2—attention deficit hyperactivity disorder	4.99e-05	0.00647	CrCbGaD
Promazine—Doxepin—SLC6A4—attention deficit hyperactivity disorder	4.97e-05	0.00643	CrCbGaD
Promazine—Doxepin—DRD2—attention deficit hyperactivity disorder	4.94e-05	0.0064	CrCbGaD
Promazine—Trifluoperazine—DRD2—attention deficit hyperactivity disorder	4.93e-05	0.00638	CrCbGaD
Promazine—Perphenazine—DRD2—attention deficit hyperactivity disorder	4.87e-05	0.00631	CrCbGaD
Promazine—Quetiapine—DRD2—attention deficit hyperactivity disorder	4.78e-05	0.00619	CrCbGaD
Promazine—Fluphenazine—HTR2A—attention deficit hyperactivity disorder	4.76e-05	0.00617	CrCbGaD
Promazine—Propiomazine—HTR2A—attention deficit hyperactivity disorder	4.58e-05	0.00593	CrCbGaD
Promazine—Desipramine—SLC6A4—attention deficit hyperactivity disorder	4.56e-05	0.0059	CrCbGaD
Promazine—Desipramine—DRD2—attention deficit hyperactivity disorder	4.53e-05	0.00587	CrCbGaD
Promazine—Clomipramine—HTR2A—attention deficit hyperactivity disorder	4.36e-05	0.00564	CrCbGaD
Promazine—Chlorprothixene—HTR2A—attention deficit hyperactivity disorder	4.34e-05	0.00561	CrCbGaD
Promazine—Thioridazine—HTR2A—attention deficit hyperactivity disorder	4.1e-05	0.00531	CrCbGaD
Promazine—Trimipramine—HTR2A—attention deficit hyperactivity disorder	4.01e-05	0.00519	CrCbGaD
Promazine—Methotrimeprazine—HTR2A—attention deficit hyperactivity disorder	3.92e-05	0.00507	CrCbGaD
Promazine—Imipramine—SLC6A4—attention deficit hyperactivity disorder	3.87e-05	0.00501	CrCbGaD
Promazine—Chlorpromazine—DRD2—attention deficit hyperactivity disorder	3.87e-05	0.00501	CrCbGaD
Promazine—Promethazine—HTR2A—attention deficit hyperactivity disorder	3.86e-05	0.005	CrCbGaD
Promazine—Imipramine—DRD2—attention deficit hyperactivity disorder	3.85e-05	0.00498	CrCbGaD
Promazine—Amitriptyline—SLC6A4—attention deficit hyperactivity disorder	3.84e-05	0.00498	CrCbGaD
Promazine—Amitriptyline—DRD2—attention deficit hyperactivity disorder	3.82e-05	0.00495	CrCbGaD
Promazine—Doxepin—HTR2A—attention deficit hyperactivity disorder	3.82e-05	0.00494	CrCbGaD
Promazine—Trifluoperazine—HTR2A—attention deficit hyperactivity disorder	3.81e-05	0.00493	CrCbGaD
Promazine—Perphenazine—HTR2A—attention deficit hyperactivity disorder	3.77e-05	0.00488	CrCbGaD
Promazine—Quetiapine—HTR2A—attention deficit hyperactivity disorder	3.69e-05	0.00478	CrCbGaD
Promazine—Desipramine—HTR2A—attention deficit hyperactivity disorder	3.5e-05	0.00454	CrCbGaD
Promazine—Chlorpromazine—HTR2A—attention deficit hyperactivity disorder	2.99e-05	0.00387	CrCbGaD
Promazine—Imipramine—HTR2A—attention deficit hyperactivity disorder	2.97e-05	0.00385	CrCbGaD
Promazine—Amitriptyline—HTR2A—attention deficit hyperactivity disorder	2.95e-05	0.00382	CrCbGaD
Promazine—ADRA1B—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	1.5e-05	9.16e-05	CbGpPWpGaD
Promazine—HTR2A—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	1.5e-05	9.15e-05	CbGpPWpGaD
Promazine—CHRM1—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	1.5e-05	9.14e-05	CbGpPWpGaD
Promazine—HRH1—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	1.5e-05	9.13e-05	CbGpPWpGaD
Promazine—CHRM3—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	1.49e-05	9.11e-05	CbGpPWpGaD
Promazine—CHRM1—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	1.49e-05	9.1e-05	CbGpPWpGaD
Promazine—CHRM3—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	1.49e-05	9.08e-05	CbGpPWpGaD
Promazine—DRD2—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	1.49e-05	9.07e-05	CbGpPWpGaD
Promazine—CHRM5—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	1.48e-05	9.06e-05	CbGpPWpGaD
Promazine—ADRA2A—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	1.48e-05	9.06e-05	CbGpPWpGaD
Promazine—HTR2A—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	1.48e-05	9.03e-05	CbGpPWpGaD
Promazine—CHRM2—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	1.48e-05	9.02e-05	CbGpPWpGaD
Promazine—DRD4—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	1.48e-05	9.02e-05	CbGpPWpGaD
Promazine—HRH1—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	1.48e-05	9.01e-05	CbGpPWpGaD
Promazine—ADRA1A—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	1.47e-05	9e-05	CbGpPWpGaD
Promazine—CHRM2—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	1.47e-05	8.99e-05	CbGpPWpGaD
Promazine—CHRM1—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	1.47e-05	8.99e-05	CbGpPWpGaD
Promazine—ADRA1A—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	1.47e-05	8.96e-05	CbGpPWpGaD
Promazine—CHRM3—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	1.47e-05	8.96e-05	CbGpPWpGaD
Promazine—ADRA2A—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	1.46e-05	8.94e-05	CbGpPWpGaD
Promazine—HTR2A—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	1.46e-05	8.92e-05	CbGpPWpGaD
Promazine—HRH1—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	1.46e-05	8.9e-05	CbGpPWpGaD
Promazine—CHRM4—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	1.46e-05	8.9e-05	CbGpPWpGaD
Promazine—ADRA2A—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	1.46e-05	8.88e-05	CbGpPWpGaD
Promazine—CHRM1—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	1.45e-05	8.87e-05	CbGpPWpGaD
Promazine—CHRM2—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	1.45e-05	8.87e-05	CbGpPWpGaD
Promazine—CHRM3—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	1.45e-05	8.85e-05	CbGpPWpGaD
Promazine—ADRA1A—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	1.45e-05	8.85e-05	CbGpPWpGaD
Promazine—CHRM2—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	1.44e-05	8.76e-05	CbGpPWpGaD
Promazine—ADRA1A—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	1.43e-05	8.74e-05	CbGpPWpGaD
Promazine—DRD4—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	1.43e-05	8.71e-05	CbGpPWpGaD
Promazine—ADRA2A—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	1.41e-05	8.63e-05	CbGpPWpGaD
Promazine—DRD1—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	1.41e-05	8.63e-05	CbGpPWpGaD
Promazine—CHRM4—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	1.41e-05	8.59e-05	CbGpPWpGaD
Promazine—CHRM5—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	1.4e-05	8.52e-05	CbGpPWpGaD
Promazine—ADRA1D—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	1.4e-05	8.51e-05	CbGpPWpGaD
Promazine—DRD4—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	1.37e-05	8.38e-05	CbGpPWpGaD
Promazine—ADRA2A—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	1.37e-05	8.36e-05	CbGpPWpGaD
Promazine—ADRA2A—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	1.36e-05	8.33e-05	CbGpPWpGaD
Promazine—CHRM3—Metabolism—TPH2—attention deficit hyperactivity disorder	1.36e-05	8.32e-05	CbGpPWpGaD
Promazine—CHRM3—Metabolism—CACNB2—attention deficit hyperactivity disorder	1.36e-05	8.32e-05	CbGpPWpGaD
Promazine—HTR2A—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	1.36e-05	8.31e-05	CbGpPWpGaD
Promazine—HRH1—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	1.36e-05	8.29e-05	CbGpPWpGaD
Promazine—CHRM4—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	1.36e-05	8.27e-05	CbGpPWpGaD
Promazine—CHRM1—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	1.35e-05	8.27e-05	CbGpPWpGaD
Promazine—CHRM3—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	1.35e-05	8.24e-05	CbGpPWpGaD
Promazine—CHRM5—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	1.35e-05	8.22e-05	CbGpPWpGaD
Promazine—CHRM3—Metabolism—DPYD—attention deficit hyperactivity disorder	1.34e-05	8.18e-05	CbGpPWpGaD
Promazine—CHRM2—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	1.34e-05	8.16e-05	CbGpPWpGaD
Promazine—ADRA1A—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	1.33e-05	8.14e-05	CbGpPWpGaD
Promazine—DRD4—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	1.33e-05	8.12e-05	CbGpPWpGaD
Promazine—ADRA2A—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	1.33e-05	8.12e-05	CbGpPWpGaD
Promazine—DRD1—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	1.33e-05	8.12e-05	CbGpPWpGaD
Promazine—ADRA1D—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	1.31e-05	8.01e-05	CbGpPWpGaD
Promazine—CHRM4—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	1.31e-05	8.01e-05	CbGpPWpGaD
Promazine—DRD4—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	1.31e-05	7.98e-05	CbGpPWpGaD
Promazine—HTR2C—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	1.3e-05	7.94e-05	CbGpPWpGaD
Promazine—CHRM5—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	1.3e-05	7.92e-05	CbGpPWpGaD
Promazine—CHRM4—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	1.29e-05	7.87e-05	CbGpPWpGaD
Promazine—DRD1—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	1.28e-05	7.84e-05	CbGpPWpGaD
Promazine—CYP2C19—Metabolism—ADRA2C—attention deficit hyperactivity disorder	1.28e-05	7.83e-05	CbGpPWpGaD
Promazine—CHRM4—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	1.27e-05	7.78e-05	CbGpPWpGaD
Promazine—ADRA1D—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	1.27e-05	7.73e-05	CbGpPWpGaD
Promazine—CHRM5—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	1.26e-05	7.67e-05	CbGpPWpGaD
Promazine—ADRA2A—Metabolism—TPH2—attention deficit hyperactivity disorder	1.25e-05	7.63e-05	CbGpPWpGaD
Promazine—ADRA2A—Metabolism—CACNB2—attention deficit hyperactivity disorder	1.25e-05	7.63e-05	CbGpPWpGaD
Promazine—ADRA1B—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	1.25e-05	7.61e-05	CbGpPWpGaD
Promazine—CHRM3—Metabolism—CACNA1C—attention deficit hyperactivity disorder	1.25e-05	7.61e-05	CbGpPWpGaD
Promazine—ADRA2A—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	1.24e-05	7.56e-05	CbGpPWpGaD
Promazine—CHRM5—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	1.24e-05	7.54e-05	CbGpPWpGaD
Promazine—ADRA2A—Metabolism—DPYD—attention deficit hyperactivity disorder	1.23e-05	7.51e-05	CbGpPWpGaD
Promazine—ADRA1D—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	1.22e-05	7.45e-05	CbGpPWpGaD
Promazine—CHRM5—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	1.22e-05	7.45e-05	CbGpPWpGaD
Promazine—HTR2C—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	1.21e-05	7.38e-05	CbGpPWpGaD
Promazine—DRD4—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	1.2e-05	7.34e-05	CbGpPWpGaD
Promazine—DRD1—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	1.2e-05	7.31e-05	CbGpPWpGaD
Promazine—CHRM4—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	1.19e-05	7.24e-05	CbGpPWpGaD
Promazine—ADRA1D—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	1.18e-05	7.21e-05	CbGpPWpGaD
Promazine—DRD1—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	1.18e-05	7.18e-05	CbGpPWpGaD
Promazine—CYP2C9—Metabolism—ADRA2C—attention deficit hyperactivity disorder	1.17e-05	7.14e-05	CbGpPWpGaD
Promazine—DRD1—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	1.16e-05	7.1e-05	CbGpPWpGaD
Promazine—ADRA1D—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	1.16e-05	7.09e-05	CbGpPWpGaD
Promazine—ADRA1B—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	1.16e-05	7.07e-05	CbGpPWpGaD
Promazine—DRD2—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	1.15e-05	7.01e-05	CbGpPWpGaD
Promazine—ADRA1D—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	1.15e-05	7e-05	CbGpPWpGaD
Promazine—ADRA2A—Metabolism—CACNA1C—attention deficit hyperactivity disorder	1.14e-05	6.98e-05	CbGpPWpGaD
Promazine—HTR2C—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	1.14e-05	6.94e-05	CbGpPWpGaD
Promazine—CHRM5—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	1.14e-05	6.94e-05	CbGpPWpGaD
Promazine—HTR2A—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	1.13e-05	6.9e-05	CbGpPWpGaD
Promazine—HRH1—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	1.13e-05	6.88e-05	CbGpPWpGaD
Promazine—CHRM1—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	1.12e-05	6.86e-05	CbGpPWpGaD
Promazine—CHRM3—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	1.12e-05	6.84e-05	CbGpPWpGaD
Promazine—CHRM2—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	1.11e-05	6.77e-05	CbGpPWpGaD
Promazine—ADRA1A—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	1.11e-05	6.76e-05	CbGpPWpGaD
Promazine—HTR2C—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	1.1e-05	6.7e-05	CbGpPWpGaD
Promazine—ADRA1B—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	1.09e-05	6.65e-05	CbGpPWpGaD
Promazine—CHRM3—Metabolism—SNAP25—attention deficit hyperactivity disorder	1.09e-05	6.65e-05	CbGpPWpGaD
Promazine—DRD1—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	1.08e-05	6.61e-05	CbGpPWpGaD
Promazine—ADRA1D—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	1.07e-05	6.52e-05	CbGpPWpGaD
Promazine—DRD2—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	1.07e-05	6.52e-05	CbGpPWpGaD
Promazine—HTR2C—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	1.06e-05	6.46e-05	CbGpPWpGaD
Promazine—ADRA1B—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	1.05e-05	6.42e-05	CbGpPWpGaD
Promazine—HRH1—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	1.05e-05	6.4e-05	CbGpPWpGaD
Promazine—CHRM1—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	1.04e-05	6.38e-05	CbGpPWpGaD
Promazine—CHRM3—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	1.04e-05	6.36e-05	CbGpPWpGaD
Promazine—CHRM3—Metabolism—ADRA2A—attention deficit hyperactivity disorder	1.04e-05	6.33e-05	CbGpPWpGaD
Promazine—CHRM2—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	1.03e-05	6.29e-05	CbGpPWpGaD
Promazine—ADRA1A—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	1.03e-05	6.28e-05	CbGpPWpGaD
Promazine—ADRA2A—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	1.03e-05	6.28e-05	CbGpPWpGaD
Promazine—HTR2C—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	1.02e-05	6.25e-05	CbGpPWpGaD
Promazine—ADRA1B—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	1.01e-05	6.18e-05	CbGpPWpGaD
Promazine—HTR2C—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	1.01e-05	6.15e-05	CbGpPWpGaD
Promazine—DRD2—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	1e-05	6.13e-05	CbGpPWpGaD
Promazine—CYP1A2—Metabolism—ADRA2C—attention deficit hyperactivity disorder	1e-05	6.1e-05	CbGpPWpGaD
Promazine—ADRA2A—Metabolism—SNAP25—attention deficit hyperactivity disorder	1e-05	6.1e-05	CbGpPWpGaD
Promazine—HTR2C—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	9.95e-06	6.07e-05	CbGpPWpGaD
Promazine—HTR2A—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	9.88e-06	6.03e-05	CbGpPWpGaD
Promazine—HRH1—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	9.86e-06	6.02e-05	CbGpPWpGaD
Promazine—CHRM1—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	9.83e-06	6e-05	CbGpPWpGaD
Promazine—ADRA1B—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	9.81e-06	5.99e-05	CbGpPWpGaD
Promazine—CHRM3—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	9.8e-06	5.98e-05	CbGpPWpGaD
Promazine—CHRM2—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	9.7e-06	5.92e-05	CbGpPWpGaD
Promazine—DRD2—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	9.7e-06	5.92e-05	CbGpPWpGaD
Promazine—ADRA1A—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	9.68e-06	5.9e-05	CbGpPWpGaD
Promazine—ADRA1B—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	9.64e-06	5.88e-05	CbGpPWpGaD
Promazine—ADRA2A—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	9.56e-06	5.83e-05	CbGpPWpGaD
Promazine—ADRA1B—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	9.52e-06	5.81e-05	CbGpPWpGaD
Promazine—HRH1—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	9.52e-06	5.81e-05	CbGpPWpGaD
Promazine—CHRM1—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	9.49e-06	5.79e-05	CbGpPWpGaD
Promazine—CHRM3—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	9.46e-06	5.77e-05	CbGpPWpGaD
Promazine—CHRM2—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	9.37e-06	5.72e-05	CbGpPWpGaD
Promazine—ADRA1A—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	9.34e-06	5.7e-05	CbGpPWpGaD
Promazine—DRD2—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	9.34e-06	5.7e-05	CbGpPWpGaD
Promazine—HTR2C—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	9.27e-06	5.65e-05	CbGpPWpGaD
Promazine—HTR2A—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	9.19e-06	5.61e-05	CbGpPWpGaD
Promazine—HRH1—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	9.17e-06	5.59e-05	CbGpPWpGaD
Promazine—CHRM1—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	9.14e-06	5.58e-05	CbGpPWpGaD
Promazine—CHRM3—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	9.11e-06	5.56e-05	CbGpPWpGaD
Promazine—DRD2—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	9.04e-06	5.52e-05	CbGpPWpGaD
Promazine—CHRM2—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	9.02e-06	5.5e-05	CbGpPWpGaD
Promazine—ADRA1A—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	9e-06	5.49e-05	CbGpPWpGaD
Promazine—ADRA2A—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	8.99e-06	5.49e-05	CbGpPWpGaD
Promazine—HTR2A—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	8.9e-06	5.43e-05	CbGpPWpGaD
Promazine—DRD2—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	8.89e-06	5.42e-05	CbGpPWpGaD
Promazine—HRH1—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	8.88e-06	5.42e-05	CbGpPWpGaD
Promazine—ADRA1B—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	8.87e-06	5.41e-05	CbGpPWpGaD
Promazine—CYP2C19—Metabolism—CACNB2—attention deficit hyperactivity disorder	8.86e-06	5.41e-05	CbGpPWpGaD
Promazine—CYP2C19—Metabolism—TPH2—attention deficit hyperactivity disorder	8.86e-06	5.41e-05	CbGpPWpGaD
Promazine—CHRM1—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	8.85e-06	5.4e-05	CbGpPWpGaD
Promazine—CHRM3—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	8.82e-06	5.38e-05	CbGpPWpGaD
Promazine—DRD2—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	8.78e-06	5.36e-05	CbGpPWpGaD
Promazine—HTR2A—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	8.75e-06	5.34e-05	CbGpPWpGaD
Promazine—CHRM2—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	8.74e-06	5.33e-05	CbGpPWpGaD
Promazine—HRH1—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	8.73e-06	5.33e-05	CbGpPWpGaD
Promazine—CYP2C19—Metabolism—DPYD—attention deficit hyperactivity disorder	8.71e-06	5.32e-05	CbGpPWpGaD
Promazine—ADRA1A—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	8.71e-06	5.32e-05	CbGpPWpGaD
Promazine—CHRM1—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	8.7e-06	5.31e-05	CbGpPWpGaD
Promazine—ADRA2A—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	8.68e-06	5.3e-05	CbGpPWpGaD
Promazine—CHRM3—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	8.67e-06	5.29e-05	CbGpPWpGaD
Promazine—HTR2A—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	8.64e-06	5.27e-05	CbGpPWpGaD
Promazine—HRH1—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	8.62e-06	5.26e-05	CbGpPWpGaD
Promazine—CHRM1—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	8.59e-06	5.24e-05	CbGpPWpGaD
Promazine—CHRM2—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	8.59e-06	5.24e-05	CbGpPWpGaD
Promazine—CHRM3—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	8.56e-06	5.23e-05	CbGpPWpGaD
Promazine—ADRA1A—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	8.56e-06	5.23e-05	CbGpPWpGaD
Promazine—CHRM2—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	8.48e-06	5.18e-05	CbGpPWpGaD
Promazine—ADRA1A—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	8.46e-06	5.16e-05	CbGpPWpGaD
Promazine—DRD4—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	8.43e-06	5.14e-05	CbGpPWpGaD
Promazine—ADRA2A—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	8.36e-06	5.1e-05	CbGpPWpGaD
Promazine—CHRM4—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	8.31e-06	5.07e-05	CbGpPWpGaD
Promazine—CHRM3—Metabolism—COMT—attention deficit hyperactivity disorder	8.26e-06	5.04e-05	CbGpPWpGaD
Promazine—CHRM3—Metabolism—MAOA—attention deficit hyperactivity disorder	8.2e-06	5e-05	CbGpPWpGaD
Promazine—CYP2C19—Metabolism—CACNA1C—attention deficit hyperactivity disorder	8.1e-06	4.94e-05	CbGpPWpGaD
Promazine—ADRA2A—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	8.09e-06	4.94e-05	CbGpPWpGaD
Promazine—CYP2C9—Metabolism—TPH2—attention deficit hyperactivity disorder	8.08e-06	4.93e-05	CbGpPWpGaD
Promazine—CYP2C9—Metabolism—CACNB2—attention deficit hyperactivity disorder	8.08e-06	4.93e-05	CbGpPWpGaD
Promazine—HTR2A—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	8.05e-06	4.91e-05	CbGpPWpGaD
Promazine—HRH1—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	8.03e-06	4.9e-05	CbGpPWpGaD
Promazine—ADRA2A—Hemostasis—EP300—attention deficit hyperactivity disorder	8.01e-06	4.89e-05	CbGpPWpGaD
Promazine—CHRM1—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	8e-06	4.88e-05	CbGpPWpGaD
Promazine—CHRM3—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	7.98e-06	4.87e-05	CbGpPWpGaD
Promazine—CHRM5—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	7.96e-06	4.86e-05	CbGpPWpGaD
Promazine—CYP2C9—Metabolism—DPYD—attention deficit hyperactivity disorder	7.95e-06	4.85e-05	CbGpPWpGaD
Promazine—CHRM2—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	7.9e-06	4.82e-05	CbGpPWpGaD
Promazine—ADRA1A—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	7.88e-06	4.81e-05	CbGpPWpGaD
Promazine—ADRA2A—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	7.86e-06	4.8e-05	CbGpPWpGaD
Promazine—CYP3A4—Metabolism—ADRA2C—attention deficit hyperactivity disorder	7.72e-06	4.71e-05	CbGpPWpGaD
Promazine—DRD1—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	7.59e-06	4.63e-05	CbGpPWpGaD
Promazine—ADRA2A—Metabolism—COMT—attention deficit hyperactivity disorder	7.58e-06	4.62e-05	CbGpPWpGaD
Promazine—ADRA2A—Metabolism—MAOA—attention deficit hyperactivity disorder	7.52e-06	4.59e-05	CbGpPWpGaD
Promazine—ADRA1D—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	7.49e-06	4.57e-05	CbGpPWpGaD
Promazine—CYP2C9—Metabolism—CACNA1C—attention deficit hyperactivity disorder	7.39e-06	4.51e-05	CbGpPWpGaD
Promazine—ADRA2A—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	7.32e-06	4.47e-05	CbGpPWpGaD
Promazine—CYP2C19—Metabolism—SNAP25—attention deficit hyperactivity disorder	7.08e-06	4.32e-05	CbGpPWpGaD
Promazine—CYP1A2—Metabolism—TPH2—attention deficit hyperactivity disorder	6.9e-06	4.21e-05	CbGpPWpGaD
Promazine—CYP1A2—Metabolism—CACNB2—attention deficit hyperactivity disorder	6.9e-06	4.21e-05	CbGpPWpGaD
Promazine—CYP1A2—Metabolism—DPYD—attention deficit hyperactivity disorder	6.79e-06	4.14e-05	CbGpPWpGaD
Promazine—CYP2C19—Metabolism—ADRA2A—attention deficit hyperactivity disorder	6.74e-06	4.11e-05	CbGpPWpGaD
Promazine—HTR2C—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	6.49e-06	3.96e-05	CbGpPWpGaD
Promazine—CYP2C9—Metabolism—SNAP25—attention deficit hyperactivity disorder	6.46e-06	3.94e-05	CbGpPWpGaD
Promazine—CYP1A2—Metabolism—CACNA1C—attention deficit hyperactivity disorder	6.31e-06	3.85e-05	CbGpPWpGaD
Promazine—ADRA1B—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	6.21e-06	3.79e-05	CbGpPWpGaD
Promazine—CYP2C9—Metabolism—ADRA2A—attention deficit hyperactivity disorder	6.15e-06	3.75e-05	CbGpPWpGaD
Promazine—DRD2—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	5.73e-06	3.5e-05	CbGpPWpGaD
Promazine—HRH1—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	5.62e-06	3.43e-05	CbGpPWpGaD
Promazine—CHRM1—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	5.61e-06	3.42e-05	CbGpPWpGaD
Promazine—CHRM3—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	5.59e-06	3.41e-05	CbGpPWpGaD
Promazine—CHRM2—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	5.53e-06	3.38e-05	CbGpPWpGaD
Promazine—ADRA1A—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	5.52e-06	3.37e-05	CbGpPWpGaD
Promazine—CYP1A2—Metabolism—SNAP25—attention deficit hyperactivity disorder	5.52e-06	3.37e-05	CbGpPWpGaD
Promazine—CYP2C19—Metabolism—COMT—attention deficit hyperactivity disorder	5.37e-06	3.28e-05	CbGpPWpGaD
Promazine—CYP2C19—Metabolism—MAOA—attention deficit hyperactivity disorder	5.33e-06	3.25e-05	CbGpPWpGaD
Promazine—CYP3A4—Metabolism—CACNB2—attention deficit hyperactivity disorder	5.33e-06	3.25e-05	CbGpPWpGaD
Promazine—CYP3A4—Metabolism—TPH2—attention deficit hyperactivity disorder	5.33e-06	3.25e-05	CbGpPWpGaD
Promazine—CYP1A2—Metabolism—ADRA2A—attention deficit hyperactivity disorder	5.25e-06	3.21e-05	CbGpPWpGaD
Promazine—CYP3A4—Metabolism—DPYD—attention deficit hyperactivity disorder	5.24e-06	3.2e-05	CbGpPWpGaD
Promazine—CYP2C19—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	5.17e-06	3.15e-05	CbGpPWpGaD
Promazine—ADRA2A—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	5.13e-06	3.13e-05	CbGpPWpGaD
Promazine—CYP2C9—Metabolism—COMT—attention deficit hyperactivity disorder	4.89e-06	2.99e-05	CbGpPWpGaD
Promazine—CYP3A4—Metabolism—CACNA1C—attention deficit hyperactivity disorder	4.87e-06	2.97e-05	CbGpPWpGaD
Promazine—CYP2C9—Metabolism—MAOA—attention deficit hyperactivity disorder	4.86e-06	2.97e-05	CbGpPWpGaD
Promazine—CYP2C9—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	4.71e-06	2.88e-05	CbGpPWpGaD
Promazine—DRD4—Signaling Pathways—EP300—attention deficit hyperactivity disorder	4.46e-06	2.72e-05	CbGpPWpGaD
Promazine—CHRM4—Signaling Pathways—EP300—attention deficit hyperactivity disorder	4.4e-06	2.69e-05	CbGpPWpGaD
Promazine—CYP3A4—Metabolism—SNAP25—attention deficit hyperactivity disorder	4.26e-06	2.6e-05	CbGpPWpGaD
Promazine—CHRM5—Signaling Pathways—EP300—attention deficit hyperactivity disorder	4.22e-06	2.57e-05	CbGpPWpGaD
Promazine—CYP1A2—Metabolism—COMT—attention deficit hyperactivity disorder	4.18e-06	2.55e-05	CbGpPWpGaD
Promazine—CYP1A2—Metabolism—MAOA—attention deficit hyperactivity disorder	4.15e-06	2.53e-05	CbGpPWpGaD
Promazine—CYP3A4—Metabolism—ADRA2A—attention deficit hyperactivity disorder	4.05e-06	2.47e-05	CbGpPWpGaD
Promazine—CYP1A2—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	4.03e-06	2.46e-05	CbGpPWpGaD
Promazine—DRD1—Signaling Pathways—EP300—attention deficit hyperactivity disorder	4.02e-06	2.45e-05	CbGpPWpGaD
Promazine—ADRA1D—Signaling Pathways—EP300—attention deficit hyperactivity disorder	3.97e-06	2.42e-05	CbGpPWpGaD
Promazine—CHRM3—Metabolism—EP300—attention deficit hyperactivity disorder	3.54e-06	2.16e-05	CbGpPWpGaD
Promazine—HTR2C—Signaling Pathways—EP300—attention deficit hyperactivity disorder	3.44e-06	2.1e-05	CbGpPWpGaD
Promazine—ADRA1B—Signaling Pathways—EP300—attention deficit hyperactivity disorder	3.29e-06	2.01e-05	CbGpPWpGaD
Promazine—ADRA2A—Metabolism—EP300—attention deficit hyperactivity disorder	3.25e-06	1.98e-05	CbGpPWpGaD
Promazine—CYP3A4—Metabolism—COMT—attention deficit hyperactivity disorder	3.23e-06	1.97e-05	CbGpPWpGaD
Promazine—CYP3A4—Metabolism—MAOA—attention deficit hyperactivity disorder	3.2e-06	1.96e-05	CbGpPWpGaD
Promazine—DRD2—Signaling Pathways—EP300—attention deficit hyperactivity disorder	3.03e-06	1.85e-05	CbGpPWpGaD
Promazine—HTR2A—Signaling Pathways—EP300—attention deficit hyperactivity disorder	2.99e-06	1.82e-05	CbGpPWpGaD
Promazine—HRH1—Signaling Pathways—EP300—attention deficit hyperactivity disorder	2.98e-06	1.82e-05	CbGpPWpGaD
Promazine—CHRM1—Signaling Pathways—EP300—attention deficit hyperactivity disorder	2.97e-06	1.81e-05	CbGpPWpGaD
Promazine—CHRM3—Signaling Pathways—EP300—attention deficit hyperactivity disorder	2.96e-06	1.81e-05	CbGpPWpGaD
Promazine—CHRM2—Signaling Pathways—EP300—attention deficit hyperactivity disorder	2.93e-06	1.79e-05	CbGpPWpGaD
Promazine—ADRA1A—Signaling Pathways—EP300—attention deficit hyperactivity disorder	2.92e-06	1.78e-05	CbGpPWpGaD
Promazine—ADRA2A—Signaling Pathways—EP300—attention deficit hyperactivity disorder	2.72e-06	1.66e-05	CbGpPWpGaD
Promazine—CYP2C19—Metabolism—EP300—attention deficit hyperactivity disorder	2.3e-06	1.4e-05	CbGpPWpGaD
Promazine—CYP2C9—Metabolism—EP300—attention deficit hyperactivity disorder	2.1e-06	1.28e-05	CbGpPWpGaD
Promazine—CYP1A2—Metabolism—EP300—attention deficit hyperactivity disorder	1.79e-06	1.09e-05	CbGpPWpGaD
Promazine—CYP3A4—Metabolism—EP300—attention deficit hyperactivity disorder	1.38e-06	8.45e-06	CbGpPWpGaD
